Samsung Biologics turns 14, eyes W5tr milestone on global expansion
Founded in 2011, Samsung Biologics has rapidly ascended to become a top-tier global CDMO, with further capacity and portfolio expansion on the horizon
Samsung Biologics, the biotech arm of Samsung Group, celebrated its 14th anniversary on Monday and reaffirmed its commitment to global biopharmaceutical leadership, guided by a growth strategy built on three pillars: production capacity, portfolio diversification and global expansion.
After posting a record 4.5 trillion won ($3.2 billion) in sales last year, the company is now aiming for 5 trillion won this year — just five years after it first crossed the 1 trillion won mark in 2020.
'Over the past 14 years, Samsung Biologics has provided top-quality service to global clients and led the contract development and manufacturing organization market,' said CEO John Rim. 'We will continue to make proactive investments to enhance our competitiveness as we work together to realize our vision of enriching human life.'
Since entering the biopharmaceutical CDMO market in 2011 as a latecomer, Samsung Biologics has swiftly risen to industry leadership through aggressive capacity expansion and a rigorous focus on quality.
Its growth momentum was accelerated under the leadership of John Rim, who took the helm as CEO in late 2020. His 35 years of experience in the biopharmaceutical industry, along with an extensive global network, has helped the company break records in both orders and sales.
The production scale of the Korean biopharmaceutical company is now at an all-time high.
The company currently holds the world's largest biomanufacturing capacity at 784,000 liters, while maintaining top-tier inspection pass rates and securing more than 350 manufacturing approvals from global regulatory authorities.
With the completion of its fifth plant this month, which would add 180,000 liters of capacity, the company plans to build three additional facilities of similar scale by 2032, aiming for a total production capacity of approximately 1.32 million liters.
The company's expanded capacity is closely tied to its high volume of contract deals.
With 17 of the world's top 20 pharmaceutical companies now among its clients, the company has been bringing its presence closer to key partners through overseas offices in places such as New Jersey and Tokyo.
Since its founding, the company has secured 99 contract manufacturing agreements and 133 contract development deals, with cumulative orders totaling $16.3 billion.
Samsung Biologics surpassed 5 trillion won in total annual contract volume last year, driven in part by three major deals, each valued at over 1 trillion won. In January, the company secured its largest-ever contract manufacturing agreement worth 2.07 trillion won.
Samsung Biologics is also broadening its portfolio as part of its efforts to expand its global footprint.
In March, the company began operating a dedicated facility for antibody-drug conjugates, marking a strategic move into the market for next-generation cancer therapeutics. Future investments, the company said, will focus on new modalities, particularly in cell and gene therapies.
Beyond its commercial growth, the company remains committed to environmental, social and corporate governance initiatives within the biopharma sector.
In February, the company received the "Leadership" designation (A- rating) from the Carbon Disclosure Project in recognition of its efforts to mitigate climate-related risks.
According to the company, CEO John Rim is currently involved in the Sustainable Markets Initiative — a platform led by King Charles III to advance a sustainable future — which aims to decarbonize health care systems in collaboration with global partners.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
6 hours ago
- Korea Herald
Political uncertainty falls below pre-martial law levels: BOK
The level of political uncertainty in South Korea has returned to levels seen prior to the martial law incident, following the recent presidential election, the central bank said Friday. According to data submitted by the Bank of Korea to Rep. Cha Gyu-geun of the Rebuilding Korea Party, the political uncertainty index stood at 1.5 as of June 4, the day after the election, in which Democratic Party candidate Lee Jae-myung defeated conservative rival Kim Moon-soo. The index, which had been around 0.4 in early December, spiked to a record high of 12.8 in mid-December, following former President Yoon Suk Yeol's surprising declaration of martial law on Dec. 3. Though the index rose slightly above 1 after the election, the BOK noted that such minor fluctuations are common in normal times and should not be interpreted as meaningful. The index is compiled by the BOK's research department by tallying the number of media articles that include both the keywords "politics" and "uncertainty" in their headlines or main text. It reflects relative values, with the long-term average from the beginning of 2000 set at zero, the BOK said. The previous record high was 8.8, recorded on March 17, 2004, following the passage of the impeachment motion against the late former President Roh Moo-hyun. The economic uncertainty index also fell to 1.2 as of June 4, a level similar to the 1.1 recorded on Dec. 3. The index had surged to 5.4 on Jan. 2 but gradually declined, reaching as low as 0.5 on May 15, the BOK said. "The political uncertainty that has weighed on the economy over the past six months is expected to ease significantly," BOK Gov. Rhee Chang-yong said at a press briefing last week. "Political factors are no longer having a meaningful impact on the won-dollar exchange rate." The Korean won had weakened sharply earlier this year, nearing 1,500 won per US dollar, largely due to the domestic political turmoil and concerns over the sweeping tariff measures under US President Donald Trump's administration. But it rebounded to its strongest level in about seven months Thursday, closing at 1,358.4 won per dollar. (Yonhap)
Korea Herald
8 hours ago
- Korea Herald
Korean shipbuilders suffer 35% drop in orders through May: report
South Korean shipbuilders saw a 35 percent year-on-year drop in new orders from January to May, according to shipping industry tracker Clarkson Research Services on Thursday. During the five-month period, Korean shipbuilders secured a total of 3.81 million compensated gross tonnage, representing 24 percent of the global market — second to China, which led with 7.86 million CGT, or 49 percent. The decline is partly attributed to selective order-taking, as Korea's major shipbuilders — HD Hyundai Heavy Industries, Hanwha Ocean and Samsung Heavy Industries — have prioritized high-value-added vessels such as liquefied natural gas carriers rather than container ships. Their docks are currently occupied with orders scheduled for delivery over the next three years. However, the drop in orders is also reflects a sharp downturn in the global shipbuilding market. Total new global orders during the period fell 45 percent from a year earlier to 15.92 million CGT, raising concerns among some industry observers about the possibility of the current market cycle slowing in the coming years. Industry sources noted that many shipping companies are delaying new orders amid uncertainties in global trade and falling freight rates, driven in part by ongoing geopolitical tensions between the US and China. The Shanghai Containerized Freight Index, a widely used indicator of shipping rates, exceeded 3,000 in June last year but dropped to just over 1,200 in May this year. Although it has seen a sharp rise over the past three weeks, securities firms suggest this is a temporary increase driven by the US' short-term tariff deferral on Chinese goods. As a result, Korean shipbuilders saw a decrease in their backlog, with total outstanding orders falling by 8 percent, or 3.09 million CGT, compared to the same period last year. As of early June, HD Korea Shipbuilding & Offshore Engineering — parent company of HD Hyundai Heavy Industries and two other smaller shipbuilders — had only achieved 38.7 percent of its annual order target of $18 billion. Samsung Heavy Industries had reached 27 percent of its full-year sales goal of $9.8 billion.
Korea Herald
9 hours ago
- Korea Herald
Tim Hortons shuts down first directly operated store in Korea, reflects global brand challenges
Canadian coffee brand Tim Hortons, operated in Korea by BKR, closed its Cheongna location in Incheon on Sunday, according to industry sources on Friday. This marks the first closure of a directly operated store since the brand entered Korea, coming just over a year after the location opened in April 2024. Industry experts attribute the decision to multiple factors, including declining profitability and the fierce competition within the saturated Korean coffee market. 'We are currently looking for a more suitable location within the Incheon area to better deliver the brand's original Canadian identity and emotional appeal to a broader range of consumers,' a Tim Hortons official said. Likewise, global coffee brands that have seen success overseas are finding it difficult to gain traction in Korea. Several coffee chains with strong brand loyalty in North America and Japan have recently scaled back or withdrawn their operations in the Korean market. US coffee brand Blue Bottle Coffee is also facing challenges in maintaining profitability. Since launching its first Korean store in Seoul's trendy Seongsu-dong neighborhood in 2019, Blue Bottle has rapidly expanded into key commercial districts. However, the brand now struggles under high fixed costs and intense market saturation. Blue Bottle Coffee Korea's revenue rose to 31.1 billion won ($22.9 million) in 2024, a 17 percent increase from 26.4 billion won in 2023. However, operating profit plummeted by 89 percent, reaching just 200 million won. The company also posted a net loss of 1.1 billion won, marking its first annual loss since entering the Korean market. Industry insiders point to the rapid pace of trend shifts and the unique dynamics of the Korean retail environment as key challenges for foreign coffee brands in Korea. 'Just a decade ago, Korea was often seen as a fallback market for global brands that had lost momentum elsewhere,' an industry official from the food and beverage sector said. 'But now, it's the opposite — if a brand can break through and gain a foothold with Korea's trend-sensitive consumers, it's seen as a stepping stone for faster, easier success in other Asian markets.' Such challenges are not limited to the food and beverage sector. Global beauty retail giant Sephora entered Korea in 2019, opening its first store in Parnas Mall in Seoul's Gangnam district. However, it withdrew from the Korean market in the first half of 2024 after just five years, unable to compete with domestic leader Olive Young. Just before its exit, Sephora Korea posted 13.7 billion won in sales in 2023, but suffered a hefty operating loss of 17.6 billion won.
